Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide is a novel medication that has recently gained attention for its dual role in managing both type 2 diabetes and obesity. Approved by the FDA under the brand names Mounjaro and Zepbound, tirzepatide acts as a dual agonist for the glucagon-like peptide-1 (GLP-1) receptor and the glucose-de

The Mechanism of Action

Understanding how tirzepatide functions can provide clarity on its effectiveness in weight loss. When we consume food, PlexusDx's body releases hormones like GLP-1 and GIP, which play pivotal roles in regulating insulin secretion and appetite. Tirzepatide mimics these natural hormones, leading to several beneficial effects:

  • Increased Insulin Secretion: Tirzepatide stimulates the pancreas to release insulin when blood sugar levels are high, helping to manage glucose levels effectively.
  • Appetite Suppression: By acting on the brain’s appetite centers, tirzepatide reduces hunger signals, which can lead to decreased caloric intake.
  • Slowed Gastric Emptying: This helps prolong the feeling of fullness after eating, further supporting weight loss efforts.

The combination of these effects makes tirzepatide a powerful tool in the fight against obesity, especially when combined with lifestyle changes such as diet and exercise.

Average Dosage of Tirzepatide for Weight Loss

When it comes to using tirzepatide for weight loss, dosage is a crucial factor in determining its effectiveness and safety. At PlexusDx, we emphasize a personalized approach to weight loss, and this extends to medication dosing.

The typical dosing schedule for tirzepatide in the context of weight loss begins with a lower dose to assess tolerance and minimize potential side effects. Here’s a breakdown of the average dosing regimen:

  1. Initial Dose: The starting dose is usually 2.5 mg once a week for the first four weeks. This allows the body to adjust to the medication while monitoring for any adverse reactions.

  2. Dose Adjustment: After four weeks, if well-tolerated, the dosage can be increased to 5 mg weekly. Further increments of 2.5 mg can be made every four weeks based on individual response and weight loss progress.

  3. Maintenance Dose: The maximum recommended dose for weight loss is 15 mg once a week. However, the optimal maintenance dose may vary based on individual factors such as tolerance, weight loss goals, and any side effects experienced.

Initial Dose : The starting dose is usually 2.5 mg once a week for the first four weeks. This allows the body to adjust to the medication while monitoring for any adverse reactions.

Dose Adjustment : After four weeks, if well-tolerated, the dosage can be increased to 5 mg weekly. Further increments of 2.5 mg can be made every four weeks based on individual response and weight loss progress.

Expected Weight Loss Results

Clinical trials have demonstrated the efficacy of tirzepatide in promoting weight loss. In studies, participants using tirzepatide experienced significant reductions in body weight over a 72-week period. For example:

  • Those on a 5 mg weekly dose lost an average of 16.1 kg (35.5 lbs).
  • Participants receiving the 10 mg dose saw an average weight loss of 22.2 kg (48.9 lbs).
  • The highest dose of 15 mg was associated with an average weight loss of 23.6 kg (52.0 lbs).

These results highlight the potential of tirzepatide as an effective weight management solution, particularly when combined with lifestyle modifications.

Side Effects and Considerations

While tirzepatide offers promising results, it’s essential to be aware of potential side effects. Common reactions may include:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Constipation

Though many users tolerate tirzepatide well, some may experience more severe reactions such as pancreatitis or allergic reactions. It is crucial to discuss your medical history with your healthcare provider to ensure that tirzepatide is a safe option for you, particularly if you have any underlying health conditions.

FAQ

What is the typical weight loss seen with tirzepatide?

How can I start my weight loss journey with tirzepatide?

Can I combine tirzepatide with other weight loss strategies?

By understanding the average dose of tirzepatide for weight loss, you are taking an important step toward achieving your weight management goals effectively and safely. At PlexusDx, we are here to support you on this journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How does tirzepatide aid in weight loss?

Tirzepatide aids in weight loss by mimicking two hormones (GLP-1 and GIP) that regulate appetite and insulin secretion, leading to reduced hunger and increased feelings of fullness.

What is the typical weight loss seen with tirzepatide?

Patients using tirzepatide for weight loss can expect to lose between 16.1 kg (35.5 lbs) and 23.6 kg (52.0 lbs) depending on the dosage and individual response.

How should tirzepatide be administered?

Tirzepatide is administered as a subcutaneous injection once a week, typically into the abdomen, thigh, or upper arm. It’s important to rotate injection sites to avoid irritation.

Who should avoid using tirzepatide?

Individuals with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 should avoid tirzepatide. Always consult your healthcare provider regarding potential contraindications.

How can I start my weight loss journey with tirzepatide?

To begin your journey, take PlexusDx's free assessment quiz to determine your eligibility for tirzepatide and receive a personalized treatment plan tailored to your needs.

Can I combine tirzepatide with other weight loss strategies?

Yes, tirzepatide is most effective when combined with lifestyle changes such as a healthy diet and regular exercise. It’s important to discuss any additional strategies with your healthcare provider to ensure a comprehensive approach.

Related Reading

Pricing and availability current as of May 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves